Methylprednisolone Completed Phase 2 Trials for Progressive Multiple Sclerosis Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01305837Cyclic Oral Methylprednisolone Trial in Multiple Sclerosis